Published:
Health Robotics Announces i.v.STATION(TM) Contract With Grifols in Spain, Portugal and South America
BOZEN , Italy , June 29 /PRNewswire/ -- Health-Robotics today announced
that it has signed an exclusive 5-year strategic partnership with Grifols
S.A., the leading Pharmacy Automation provider in Spain , Portugal , and South
America . Grifols desires to safely, accurately, and cost-effectively automate
the preparation of non-hazardous IV Admixtures with Health Robotics'
i.v.STATION Robot. As part of this strategic partnership, Grifols will take
delivery of 120 i.v.STATION Robots between now and December 2014 for
deployment in Spain , Portugal , Chile , Brazil , Argentina , Uruguay , Paraguay ,
Peru , Ecuador , Bolivia , Venezuela , Colombia , Honduras , Costa Rica , Panama , El
Salvador , Nicaragua , Guatemala , Surinam , Guyana , Belize , and French Guyana.
"We are very pleased to have been chosen by Health Robotics as their
exclusive i.v.STATION partner in our core markets. i.v.STATION represents an
ideal complement to other oral medication automation products such as
BlisPack, Pyxis' MedStation, Kardex Carroussels, and to our systems for IV
preparation as Misterium clean rooms or the Grifill sterile compounding
device sector in which we hold a commanding lead inSpain,Portugal andSouth
America with over 200 hospitals utilizing our Pharmacy Automation technology.
Grifols believes that i.v.STATION has the real potential to revolutionize
Pharmacy Automation for IVs patient doses globally," stated Ramon Riera,
Executive Member of the Board of Directors and Vice President of Marketing
and Sales, Grifols.
i.v.STATION represents a revolutionary approach in the quest for safe,
accurate, efficient, cost effective, and ready-to-administer IV Admixtures.
Constructed around a scalable, distributed, and fail-safe architecture,
i.v.STATION offers unprecedented final container flexibility, life-critical
patient safety, and robotic precision and performance. i.v.STATION may be
deployed in a variety of locations, including central and satellite
pharmacies and direct patient care areas, due to its self-contained form, ISO
Class 5 environment, and small "foot print". Pharmacies may, for the first
time, choose a robotic configuration that suits their needs, rather than
being forced into the dated alternative of "one-size-fits-all,
million-dollar-plus" robots designed 10 years ago. Whether a Pharmacy chooses
a single or multiple i.v.STATION configurations, it will benefit from fully
automated compounding while producing its ready-to-administer IV doses in a
variety of syringe, bag, vial, and tamper-evident caps from diverse medical
suppliers.
"Grifols is everything we look for in a strategic partner for Health
Robotics: company stability, world-class service infrastructure,
well-developed marketing channels, and experience in IV therapy, clinical
nutrition, and pharmacy automation. I was extremely impressed to see their
manufacturing and biomedical expertise and the large footprint they have
achieved with over 100 hospitals utilizing Pyxis MedStation technologies in
their core markets. I hope this is just the beginning of a long-term
partnership expanding into manufacturing and other unexplored fields in
Robotics pharmacy automation such as total parenteral nutrition," stated
Werner Rainer, Health Robotics' CEO.
About Health Robotics:
Health Robotics is the global leading supplier of life-critical
intravenous medication preparation, compounding, and dispensing Robots, with
fifty times more units sold that all of its competitors combined, and
providing healthcare facilities in four continents with robotics technology
and software automation solutions. The world-leading solutions CytoCare
(hazardous IVs), i.v.STATION (non-hazardous IVs), and the current development
of TPNstation (parenteral nutrition) have and will greatly contribute to ease
global hospitals' and clinics' growing pressures to improve patient safety
through the effective and efficient production of sterile, accurate, and
ready-to-administer IVs, to eliminate life-threatening drug-exchange errors,
to decrease other medication errors and contamination risks, and to work more
efficiently, increase throughput, reduce waste, and contain costs.
About Grifols:
Grifols S.A. is aSpain-based company engaged in the healthcare sector
and is listed on Ibex-35 stock market. Grifols is involved in the research,
development, manufacturing and marketing of plasma derivates, IV therapy
solutions, enteral and parenteral nutrition, diagnostic systems, pharmacy
automation, and medical materials and devices. Founded in 1940, Grifols
currently operates in 90 countries with more than 6.000 employees, 26
subsidiaries with combined gross revenues over euro 800 million, and a euro 3
billion market capitalization.
For additional information, please contact:
Health Robotics
Gaspar G. DeViedma
Altmanstrasse 9A, Bozen, Sud-Tyrol, I-39100
USA: +1-609-980-7976
Europe: +39-346-963-4934
gaspar.deviedma@health-robotics.com
Grifols
Raquel Lumbreras
Gabinete de Prensa Grifols
Europe: +34-91-311-9289 / +91-221-7448 / +34-659-572-185
Raquel_lumbreras@duomocomunicacion.com
SOURCE Health Robotics
Copyright © 2009, PRNewswire
Copyright © 2009, NewsBlaze,
Daily News
Tags: ,MTC,NAN,MEQ,PHA,CON,Pharmacy-Automation-C
_ _